Skip to main content
. 2020 Jan 1;11(1):208–212. doi: 10.7150/jca.36513

Table 2.

Korean gastric cancer patients with CDH1 V832M germline mutation identified in this study

ID Sex Age at diagnosis Lauren's classification WHO classification TNM classification EBV infectiona MSI stateb H. pylori infectionc Family history of cancer (affected family member) Other cancer histories in a patient (age at diagnosis)
P41 F 50 Diffuse Poorly cohesive Stage IA Negative MSS Negative None Papillary thyroid cancer (49)
P93 F 58 Intestinal Tubular Stage IA Negative MSS Not done Colon cancer (a brother) None
P119 M 62 Intestinal Tubular Stage IIIA Positive MSS Not done None None
P143 F 66 Intestinal Tubular Stage IIA Negative MSI-H Not done Lymphoma (a son) None
P154 M 66 Intestinal Tubular Stage IIB Negative MSS Positive Unknown Unknown
P186 M 41 Intestinal Tubular Stage IA Negative MSS Negative Gastric cancer (a father) None
P253 M 75 Diffuse Tubular Stage IIB Negative MSI-H Negative Unknown Unknown

EBV, Epstein-Barr virus; MSI, microsatellite instability; H. pylori, Helicobacter pylori; MSS, microsatellite stability; MSI-H, microsatellite instability high. aEBV infection was detected using in-situ hybridization or real-time PCR. bMicrosatellite instability status was determined by the mononucleotide repeat markers NR-21, BAT-26, BAT-25, NR-24, and NR-27. MSI-H was defined as a tumor with two or more of the five markers of instability, and MSS was defined as the absence of any marker. cH. Pylori infection was detected using Giemsa stain or PCR and sequencing.